DE3887856T2 - Methode zur Herstellung von natürlichen, menschlichen Wachstumshormon in reiner Form. - Google Patents

Methode zur Herstellung von natürlichen, menschlichen Wachstumshormon in reiner Form.

Info

Publication number
DE3887856T2
DE3887856T2 DE3887856T DE3887856T DE3887856T2 DE 3887856 T2 DE3887856 T2 DE 3887856T2 DE 3887856 T DE3887856 T DE 3887856T DE 3887856 T DE3887856 T DE 3887856T DE 3887856 T2 DE3887856 T2 DE 3887856T2
Authority
DE
Germany
Prior art keywords
growth hormone
natural
pure form
precursor
hgh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3887856T
Other languages
English (en)
Other versions
DE3887856D1 (de
Inventor
Guido Grandi
Elisabetta Franchi
Federico Maisano
Testori Silvia Astrua
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Eniricerche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche SpA filed Critical Eniricerche SpA
Publication of DE3887856D1 publication Critical patent/DE3887856D1/de
Application granted granted Critical
Publication of DE3887856T2 publication Critical patent/DE3887856T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE3887856T 1987-12-22 1988-12-21 Methode zur Herstellung von natürlichen, menschlichen Wachstumshormon in reiner Form. Expired - Lifetime DE3887856T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23148/87A IT1223577B (it) 1987-12-22 1987-12-22 Procedimento migliorato per la preparazione dell'ormone della crescita umano naturale in forma pura

Publications (2)

Publication Number Publication Date
DE3887856D1 DE3887856D1 (de) 1994-03-24
DE3887856T2 true DE3887856T2 (de) 1994-05-19

Family

ID=11204294

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3887856T Expired - Lifetime DE3887856T2 (de) 1987-12-22 1988-12-21 Methode zur Herstellung von natürlichen, menschlichen Wachstumshormon in reiner Form.

Country Status (7)

Country Link
US (1) US5047333A (de)
EP (1) EP0321940B1 (de)
JP (1) JPH022386A (de)
AT (1) ATE101649T1 (de)
DE (1) DE3887856T2 (de)
ES (1) ES2061619T3 (de)
IT (1) IT1223577B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
EP0564531B1 (de) * 1990-12-03 1998-03-25 Genentech, Inc. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
US5780279A (en) * 1990-12-03 1998-07-14 Genentech, Inc. Method of selection of proteolytic cleavage sites by directed evolution and phagemid display
IT1244477B (it) * 1990-12-21 1994-07-15 Eniricerche Spa Ceppo asporigeno di bacillus subtilis e suo impiego come ospite per la preparazione di prodotti eterologhi
IT1245385B (it) * 1991-03-28 1994-09-20 Eniricerche Spa Procedimento migliorato per la preparazione di polipeptidi maturi
IT1251895B (it) * 1991-09-27 1995-05-26 Eniricerche Spa Mutanti dell'ormone della crescita umano e loro impiego
IT1270866B (it) * 1993-03-10 1997-05-13 Eniricerche Spa Vettore ricombinante e suo impiego per la preparazione esocellulare di anticorpi in forma di singola molecola da bacillus subtilis
WO1999045020A1 (en) * 1998-03-04 1999-09-10 Bio-Technology General Corp. Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
AU2004320986A1 (en) * 2004-06-23 2006-01-05 Usv Limited Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera
CA2565209A1 (en) * 2004-11-09 2006-05-18 Usv Limited A novel process for purification of human growth harmone
KR101527528B1 (ko) * 2012-09-19 2015-06-19 한국표준과학연구원 가용성 재조합 단백질의 생산, 추출 및 정제 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
DK55685A (da) * 1985-02-07 1986-08-08 Nordisk Gentofte Enzym eller enzymkompleks med proteolytisk aktivitet
GB8412517D0 (en) * 1984-05-16 1984-06-20 Nagai K Recombinant fusion proteins
CA1340522C (en) * 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
IT1228925B (it) * 1987-08-07 1991-07-10 Eniricerche Spa Procedimento per la preparazione dell'ormone della crescita umano

Also Published As

Publication number Publication date
ES2061619T3 (es) 1994-12-16
ATE101649T1 (de) 1994-03-15
EP0321940A3 (en) 1990-05-23
DE3887856D1 (de) 1994-03-24
US5047333A (en) 1991-09-10
IT1223577B (it) 1990-09-19
IT8723148A0 (it) 1987-12-22
EP0321940B1 (de) 1994-02-16
JPH022386A (ja) 1990-01-08
EP0321940A2 (de) 1989-06-28

Similar Documents

Publication Publication Date Title
US4604234A (en) Protein having cell growth stimulating action, composition thereof and method for producing the same
Carrel et al. The chemical nature of substances required for cell multiplication
EP2210947A3 (de) Procédé de production de protéines sécrétées
DE3887856D1 (de) Methode zur Herstellung von natürlichen, menschlichen Wachstumshormon in reiner Form.
SG161210A1 (en) Methods for expression and purification of recombinant human growth hormone
DE122004000009I2 (de) Methode zur Herstellung von menschlichen Wachstumshormonen
DE69735510D1 (de) Verfahren zur Herstellung eines rekombinanten Polypeptids unter Hinzufügung eines Chymotrypsinhemmstoffes zum Zellkulturmedium
EP0111389A3 (de) Wesentlich sauberes Schweinewachstumshormon, DNS-Sequenzen dafür und Expressionsvektoren und transfektierte Mikroorganismen zur Herstellung von Schweinewachstumshormon
AU7506396A (en) Composition for improving pancreatic function
EP0468411B1 (de) Mutanter Stamm von Clostridium histolyticum, Verfahren zu dessen Herstellung und Verwendung zur Herstellung von Clostripain-freier Kollagenase
DE3879823D1 (de) Verfahren zur herstellung von menschlichem wachstumshormon.
ES8606485A1 (es) Procedimiento para preparar una solucion antigenica libre decelulas
HUT55036A (en) Process for producing polypeptides blocking the calcium duct
MY116149A (en) Seasoning production
ES2229250T3 (es) Procedimiento para el aprovechamiento del sistema promotor de pa-adh en una levadura para la produccion por via biiotecnologica de proteinas heterologas en altos rendimientos.
AUPM772494A0 (en) Improvements in production of proteins in host cells
ZA9610233B (en) Process of preparing an organic acid
AU1090688A (en) Synthetic porcine growth hormone
ATE451469T1 (de) In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten
EP0390327A3 (de) Verfahren zur Züchtung von Gewebekulturen
EP0189587A3 (en) Method of sterilizing recombinant microorganism
AU6860294A (en) New chondrocyte proteins
JPS6486895A (en) Production of 3',5'-cyclicadenylic acid
HUT58790A (en) Process for producing cultivating medium for cell-cultures
TH18933B (th) กรรมวิธีสำหรับผลิตสารประกอบเอไมด์โดยใช้จุลินทรีย์

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PHARMACIA AB, STOCKHOLM, SE